NCT02557321 2023-11-21PV-10 in Combination With Pembrolizumab for Treatment of Metastatic MelanomaProvectus PharmaceuticalsPhase 1/2 Unknown50 enrolled
NCT02693067 2023-02-08A Phase 1 Study of PV-10 Chemoablation of Neuroendocrine Tumours (NET) Metastatic to the LiverProvectus PharmaceuticalsPhase 1 Unknown12 enrolled